D, R., K, B., F, K., & JE, H. (2020). Ruxolitinib cream for the treatment of vitiligo - Authors' reply. Lancet (London, England), 396(10264), 1736. https://doi.org/10.1016/S0140-6736(20)32470-3
Chicago Style (17th ed.) CitationD, Rosmarin, Butler K, Kuo F, and Harris JE. "Ruxolitinib Cream for the Treatment of Vitiligo - Authors' Reply." Lancet (London, England) 396, no. 10264 (2020): 1736. https://doi.org/10.1016/S0140-6736(20)32470-3.
MLA (9th ed.) CitationD, Rosmarin, et al. "Ruxolitinib Cream for the Treatment of Vitiligo - Authors' Reply." Lancet (London, England), vol. 396, no. 10264, 2020, p. 1736, https://doi.org/10.1016/S0140-6736(20)32470-3.
Warning: These citations may not always be 100% accurate.